Oppenheimer & Co’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,199
Closed -$284K 1361
2019
Q4
$284K Buy
+5,199
New +$267K 0.01% 1044
2015
Q3
Sell
-10,354
Closed -$559K 1494
2015
Q2
$559K Sell
10,354
-138
-1% -$7.08K 0.02% 833
2015
Q1
$491K Sell
10,492
-453
-4% -$20.7K 0.01% 873
2014
Q4
$446K Buy
+10,945
New +$388K 0.01% 872

Other funds holding CDK

Oppenheimer & Co's CDK Position: Q1 2020 in Review

Oppenheimer & Co sold out of CDK Global, Inc. (CDK) in Q1 2020, closing a stake of 5,199 shares — an estimated $284K sold.

Oppenheimer & Co first reported a position in CDK in Q4 2014 and held it in 4 quarters. The position peaked at $559K in Q2 2015. 467 funds tracked by Wall St. Rank hold CDK as of Q1 2020.

  • Oppenheimer & Co reported no remaining CDK Global, Inc. position as of Q1 2020 after selling out during the quarter.
  • Oppenheimer & Co sold 5,199 CDK Global, Inc. shares in Q1 2020, an estimated $284K.
  • Oppenheimer & Co first reported a position in CDK Global, Inc. in Q4 2014 and held it in 4 quarters.
  • Oppenheimer & Co's CDK Global, Inc. position peaked at $559K in Q2 2015.
  • 467 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q1 2020.

Based on Oppenheimer & Co's 13F filing for Q1 2020, filed 8 May 2020.